박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Celltrion Secures Historic FDA Interchangeability Status for Truxima

Previous678910Next